scispace - formally typeset
V

Victoria Ivanov

Publications -  13
Citations -  4126

Victoria Ivanov is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 3 publications receiving 1855 citations.

Papers
More filters
Journal ArticleDOI

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular riskThe Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

François Mach, +120 more
Journal Article

Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” (Atherosclerosis (2019) 290 (140–205), (S0021915019314595), (10.1016/j.atherosclerosis.2019.08.014))

François Mach, +95 more
- 01 Jan 2019 - 
Journal ArticleDOI

Erratum to “2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk” [Atherosclerosis 290 (2019) 140–205]

François Mach, +97 more
- 01 Jan 2020 - 
Journal ArticleDOI

Low-grade endotoxemia and NOX-2 in patients with coronary microvascular angina.

TL;DR: This study provides the first report attesting that patients with MVA have high LPS levels, NOX-2 activation and an imbalance between pro-oxidant and antioxidant systems, in favor of the oxidizing molecules that could be potentially implicated in the endothelial dysfunction and vasoconstriction of this disease.
Journal ArticleDOI

Cardiovascular risk profile in patients with hepatic steatosis

TL;DR: The study shows that RiskFRS appeared to be most useful CVD risk assessment model in hepatic steatosis, riskFRS is likely to identify a greater number of patients at ‘high-risk’ as compared to Risk SCORE and Risk ACC/AHA.